Related Experiment Video
Updated: Sep 28, 2025

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
Published on: March 28, 2018
Primary biliary cholangitis: advances in understanding and management.
Alex Smith1, Benjamin Giles1, Richard J Aspinall1
1Portsmouth Liver Centre, Portsmouth Hospitals University NHS Trust, Queen Alexandra Hospital, Portsmouth, UK.
Primary biliary cholangitis (PBC) management has advanced, improving risk stratification and new drug development. Current guidelines focus on targeted symptom treatment and prioritizing second-line therapies for better patient outcomes.
Area of Science:
- Hepatology
- Gastroenterology
- Autoimmune Liver Disease
Background:
- Primary biliary cholangitis (PBC) understanding has significantly evolved.
- The condition's name has been updated to Primary biliary cholangitis.
- Large multicenter studies have enhanced knowledge of PBC's natural history.
Purpose of the Study:
- To summarize recent advancements in understanding Primary biliary cholangitis.
- To review the latest developments in the management of Primary biliary cholangitis.
- To highlight new approaches in risk stratification and treatment.
Main Methods:
- Review of recent large multicenter studies.
- Analysis of updated clinical guidelines.
- Synthesis of current research on Primary biliary cholangitis natural history and treatment.
Main Results:
- Improved identification of high-risk patients with Primary biliary cholangitis.
- Facilitation of new medication development for PBC.
- Emphasis on risk stratification and targeted therapies in recent guidelines.
Conclusions:
- Recent advances have clarified Primary biliary cholangitis natural history and risk factors.
- New therapeutic strategies and medications are emerging for PBC.
- Current management emphasizes personalized treatment and early intervention.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
